Table 4.

Univariate and multivariate analyses of subjects treated with nerve-sparing RP without hormone treatment.

	Timing			Tumor characteristics
r p-value	Age at RP	Follow-up duration	Age at follow-up	PSA	T-stage	Gleason score
SF*	-0.204 0.050	-0.184 0.077	-0.258 0.012	0.053 0.612	-0.207 0.046	-0.096 0.359
SB*	0.098 0.350	0.161 0.124	0.143 0.170	-0.064 0.543	-0.015 0.889	-0.031 0.771
SF#	1.841 0.303	/	-3.138 0.056	/	-12.530 0.027	/

Significant results (p ≤ 0.05) are in bold.

[SF: sexual function; SB: sexual bother./: Not included for the multivariate analyses]